Pfizer vaccine 95% effective in final analysis, company seeks final safety step | WNT

  • By cvbizz
  • November 19, 2020
  • 0
Share This Post!

Pfizer and partner BioNTech said Wednesday the company will apply for FDA emergency authorization “within days,” following the promising final analysis of the Phase 3 trial.

Upstate News Headlines

PHP Code Snippets Powered By :